Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Leukemia
|
November 30, 2019
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
Mattia D'Agostino, Noopur Raje
Frontiers in Oncology
|
March 31, 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
Francesca Bonello, Lorenzo Cani, Mattia D'Agostino
Current Hematologic Malignancy Reports
|
May 5, 2021
MRD Assessment in Multiple Myeloma: Progress and Challenges
Luca Bertamini, Mattia D'Agostino, Francesca Gay
Current Hematologic Malignancy Reports
|
August 19, 2017
Novel Immunotherapies for Multiple Myeloma
Mattia D'Agostino, Mario Boccadoro, Eric L Smith
International Journal of Molecular Sciences
|
November 3, 2020
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
Mattia D'Agostino, Salvatore Innorcia, Mario Boccadoro, et al.
Frontiers in Oncology
|
February 21, 2020
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
Stefania Oliva, Mattia D'Agostino, Mario Boccadoro, et al.
Leukemia & Lymphoma
|
November 8, 2016
Plasma cell leukemia: update on biology and therapy
Roberto Mina, Mattia D'Agostino, Chiara Cerrato, et al.
Frontiers in Immunology
|
December 13, 2018
Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
Stefania Oliva, Rossella Troia, Mattia D'Agostino, et al.
Cancers
|
December 19, 2019
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies
Mattia D'Agostino, Luca Bertamini, Stefania Oliva, et al.
Expert Review of Anticancer Therapy
|
July 5, 2018
Determining treatment intensity in elderly patients with multiple myeloma
Marco Salvini, Mattia D'Agostino, Francesca Bonello, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Leukemia
|
November 30, 2019
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
Mattia D'Agostino, Noopur Raje
Frontiers in Oncology
|
March 31, 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
Francesca Bonello, Lorenzo Cani, Mattia D'Agostino
Current Hematologic Malignancy Reports
|
May 5, 2021
MRD Assessment in Multiple Myeloma: Progress and Challenges
Luca Bertamini, Mattia D'Agostino, Francesca Gay
Current Hematologic Malignancy Reports
|
August 19, 2017
Novel Immunotherapies for Multiple Myeloma
Mattia D'Agostino, Mario Boccadoro, Eric L Smith
International Journal of Molecular Sciences
|
November 3, 2020
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
Mattia D'Agostino, Salvatore Innorcia, Mario Boccadoro, et al.
Frontiers in Oncology
|
February 21, 2020
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
Stefania Oliva, Mattia D'Agostino, Mario Boccadoro, et al.
Leukemia & Lymphoma
|
November 8, 2016
Plasma cell leukemia: update on biology and therapy
Roberto Mina, Mattia D'Agostino, Chiara Cerrato, et al.
Frontiers in Immunology
|
December 13, 2018
Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
Stefania Oliva, Rossella Troia, Mattia D'Agostino, et al.
Cancers
|
December 19, 2019
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies
Mattia D'Agostino, Luca Bertamini, Stefania Oliva, et al.
Expert Review of Anticancer Therapy
|
July 5, 2018
Determining treatment intensity in elderly patients with multiple myeloma
Marco Salvini, Mattia D'Agostino, Francesca Bonello, et al.
Page
of 7